We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Arecor Therapeutics Plc | LSE:AREC | London | Ordinary Share | GB00BMWLM973 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 128.50 | 127.00 | 130.00 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
128.50 | 128.50 | 128.50 | 3,300 | 08:00:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 3.54M | -9.26M | -0.3024 | -4.25 | 39.35M |
Date | Time | Source | Headline |
---|---|---|---|
12/3/2024 | 12:16 | ALNC | Arecor to develop "holy grail" diabetes treatment with partner TRx |
12/3/2024 | 08:58 | UK RNS | Arecor Therapeutics PLC Arecor and TRx Biosciences research collaboration |
12/3/2024 | 07:00 | UK RNS | Arecor Therapeutics PLC Arecor and TRx Biosciences research collaboration |
29/2/2024 | 19:42 | ALNC | EARNINGS AND TRADING: East Star, Getech strike Kazakhstan JV |
29/2/2024 | 07:00 | UK RNS | Arecor Therapeutics PLC Arecor announces launch of Ogluo® in Netherlands |
01/2/2024 | 14:24 | ALNC | Arecor Therapeutics hails Arestat as 2023 performance "strong" |
01/2/2024 | 07:00 | UK RNS | Arecor Therapeutics PLC Year End Trading Update |
23/1/2024 | 21:47 | ALNC | IN BRIEF: Arecor pleased as investee Inhibrx sells therapy to Sanofi |
23/1/2024 | 16:58 | UKREG | Arecor Therapeutics PLC Arecor announces update on INBRX-101 |
18/1/2024 | 18:26 | ALNC | TRADING UPDATES: Patent boosts for DG Innovate and Arecor Therapeutics |
1 Year Arecor Therapeutics Chart |
Intraday Arecor Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions